As Helicobacter pylori management has become more challenging and less efficient over
the last decade, the interest in innovative interventions is growing by the day. Probiotic co …

This review summarizes important studies regarding Helicobacter pylori therapy published
from April 2019 to April 2020. The main themes that emerge involve studies assessing …

Background Helicobacter pylori (H. pylori) is the causative agent of stomach diseases such
as duodenal ulcer and gastric cancer, in this regard incomplete eradication of this bacterium …

Background Global antibiotic use has been increasing for decades. The gut microbiome, a
key contributor to health, can be altered by antibiotics, which have been associated with …

Saccharomyces boulardii (Sb) is a widely used fungal probiotic in treating various digestive
diseases, including irritable bowel syndrome (IBS). However, the specific mechanisms of Sb …

Background Viable probiotics have shown effects on the eradication of Helicobacter pylori,
but the role of non‐viable probiotics in H. pylori eradication is unclear. This study aimed to …

Saccharomyces cerevisiae var. boulardii (S. boulardii) has been isolated from lychee (Litchi
chinensis), mangosteen fruit, kombucha, and dairy products like kefir. Dairy products …

The growing use of photosynthetic microorganisms for food and food-related applications is
driving related biotechnology research forward. Increasing consumer acceptance, high …

Background Probiotics are often used to prevent antibiotic-induced low-diversity dysbiosis,
however their effect is not yet sufficiently summarized in this regard. We aimed to investigate …

Helicobacter pylori is a highly prevalent bacteria that can harm humans due to its major
involvement in developing gastrointestinal diseases, particularly gastric cancer. Therefore …